Catalytica, Wyckoff Chemical Co. Inc. deal

CTAL completed its acquisition of Wyckoff, a manufacturer of active drug ingredients, for 4.5 million CTAL shares (see BioCentury, July 19). The business, which will operate as a division of CTAL's Catalytica Pharmaceuticals Inc. subsidiary, was renamed Wyckoff Inc. ...